Sort
30,917 grants matching “tumor microenvironment”
TME Administrative Core
$532,588Paul R Lockman · West Virginia University · P20 · FY2025 · GM
Targeting Ferritin in Glioblastoma
$532,477Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA
The Impact of Obesity on Radiotherapy Anti-Tumor Effects
$532,472Arta Monir Monjazeb · University Of California At Davis · R01 · FY2022 · CA
Targeting Ferritin in Glioblastoma
$532,412Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA
Inflammatory modulation of CXCL12 expressing niche cells in bone marrow
$532,393Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2016 · HL
Targeting Ferritin in Glioblastoma
$532,352Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · CA
Non-neoplastic cell types dictate gliomagenesis and
$532,306Dolores Hambardzumyan · Cleveland Clinic Lerner Com-Cwru · U01 · FY2014 · CA
Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer
$532,300Kyung Hyun Sung · University Of California Los Angeles · R01 · FY2024 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$532,237Lily Yang · Emory University · R01 · FY2023 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$532,237Lily Yang · Emory University · R01 · FY2022 · CA
Novel approach to attenuate small cell lung cancer growth and metastasis
$532,187Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2018 · CA
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures
$532,112Albert Folch · University Of Washington · R01 · FY2018 · CA
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures
$532,112Albert Folch · University Of Washington · R01 · FY2016 · CA
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures
$532,112Albert Folch · University Of Washington · R01 · FY2017 · CA
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures
$532,112Albert Folch · University Of Washington · R01 · FY2015 · CA
Protein Kinase Signaling in the Genotoxic Stress Response
$532,068Michael B Yaffe · Massachusetts Institute Of Technology · R35 · FY2021 · ES
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$531,996Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Inflammation as determinant of clonal selection in MPN progression
$531,949Nadia Carlesso · Beckman Research Institute/City Of Hope · R01 · FY2020 · HL
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy
$531,772Allon Moshe Klein · Harvard Medical School · R01 · FY2019 · CA
Exploring the dynamic tumor-immune ecosystem of breast cancer in heterogeneous tumor microenvironments
$531,693Stacey Deleria Finley · University Of Southern California · U01 · FY2025 · CA
Epidermal growth factor mitigates radiation-induced hematopoietic failure
$531,680John P Chute · University Of California Los Angeles · U01 · FY2014 · AI
Pathways that regulate basal and metastatic phenotypes in triple negative breast cancers
$531,677Teresa L Wood · Rbhs-New Jersey Medical School · R01 · FY2017 · CA
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
$531,608Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2023 · CA
Role of p62 in metabolic reprograming of the tumor stroma in prostate cancer
$531,494Maria Teresa Diaz Meco Conde · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer
$531,447Zihai Li · Cedars-Sinai Medical Center · P01 · FY2023 · CA